000 01653 a2200481 4500
005 20250514012057.0
264 0 _c20011218
008 200112s 0 0 eng d
022 _a0920-9964
024 7 _a10.1016/s0920-9964(00)00095-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLaakso, A
245 0 0 _aDecreased striatal dopamine transporter binding in vivo in chronic schizophrenia.
_h[electronic resource]
260 _bSchizophrenia research
_cOct 2001
300 _a115-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBrain Mapping
650 0 4 _aChronic Disease
650 0 4 _aCocaine
_xanalogs & derivatives
650 0 4 _aCorpus Striatum
_xdiagnostic imaging
650 0 4 _aDominance, Cerebral
_xphysiology
650 0 4 _aDopamine Plasma Membrane Transport Proteins
650 0 4 _aDopamine Uptake Inhibitors
_xpharmacokinetics
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMembrane Glycoproteins
650 0 4 _aMembrane Transport Proteins
_xmetabolism
650 0 4 _aNerve Tissue Proteins
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aRadioligand Assay
650 0 4 _aSchizophrenia
_xdiagnostic imaging
650 0 4 _aTomography, Emission-Computed
700 1 _aBergman, J
700 1 _aHaaparanta, M
700 1 _aVilkman, H
700 1 _aSolin, O
700 1 _aSyvälahti, E
700 1 _aHietala, J
773 0 _tSchizophrenia research
_gvol. 52
_gno. 1-2
_gp. 115-20
856 4 0 _uhttps://doi.org/10.1016/s0920-9964(00)00095-5
_zAvailable from publisher's website
999 _c11515464
_d11515464